Stacy L ChinFounder, KeepYourEquity · I get the government to write you checks

Biotech Funding Secret: Government Cash Flowing in 2026!

19 Jun 2026 · 1 min

Watch on YouTube

0:32

In this video, Stacy L. Chin explains that 2025 was a difficult year for biotech startups as venture capital retreated, causing valuations and private capital to evaporate for many early‑stage founders. She highlights that, despite the venture slowdown, the U.S. government continued to invest in biotech. Agencies such as the NIH, ARPA‑H, and the Department of Defense are already planning their 2026 funding streams, which could create one of the largest years of non‑dilutive financing available to early‑stage biotech companies. The message is that founders should look beyond traditional venture sources and prepare to tap into these upcoming government programs.

Chapters

Let's face it, 2025 was a tough year across biotech. Investors are pulling back, valuation strength and private capital nearly vanished for many early-stage founders. But here's what most founders don't realize. While venture money froze, the government kept spending in this sector. In fact, NIH, ARPA-H, and DOD are already mapping out what does their 2026 funding flow might look like in order to set the stage stage for one of the biggest non-diluted funding years yet to come.